Dr. Sangeeta Goswami, MD, PhD, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, discusses how immunotherapy for kidney cancer is changing the outlook for patients. Immunotherapy for kidney cancer—also called renal cell cancer—has tremendously changed the treatment landscape and overall survival of patients with metastatic kidney cancer.